TASCOM Co.,Ltd. (XKON:336040)

Market Cap	21.03B
Revenue (ttm)	5.53B
Net Income (ttm)	-1.74B
Shares Out	4.68M
EPS (ttm)	-824.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47
Average Volume	173
Open	4,300.00
Previous Close	4,300.00
Day's Range	4,300.00 - 4,500.00
52-Week Range	2,475.00 - 5,090.00
Beta	0.45
RSI	55.61
Earnings Date	n/a

About TASCOM

TASCOM Co.,Ltd. manufactures and distributes diabetic supplies in South Korea. Its products include blood glucose measurement system-acuraview, BD ultra fine PRO pen needle, syringes-BD ultrafine syringes, Ido sharp container, and Ido safety lancet. The company was formerly known as YIDOBIO Inc. and changed its name to TASCOM Co.,Ltd. in September 2021. TASCOM Co.,Ltd. was founded in 2014 and is headquartered in Anyang-Si, South Korea.

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2014
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 336040

Financial Performance

In 2018, TASCOM's revenue was 5.53 billion, an increase of 84.97% compared to the previous year's 2.99 billion. Losses were -1.74 billion, 35.2% more than in 2017.